ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 692597 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 692597; 2) Community: the network communities that were significantly associated with the response to NSC 692597; 3) Molecule: the relationships between components within communities and NSC 692597; 4) MDR: the compounds that were significantly associated with the NSC 692597.

NSC Compound Enrichment Correlation
NSC 753193 N-(2-(4-acetylpiperazin-1-yl)ethyl)-3-(3-chloro-5-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazole-1-carboxamide 0.0241085022307781 -0.057141201
NSC 758662 Lovastatin [USAN] 0.0241085022307781 -0.12995183
NSC 760979 Null 0.0241085022307781 0.084689787
NSC 78714 Clothixamide maleate (USAN) 0.0241085022307781 -0.0019630449
NSC 86373 Quinolinium, 4-[2-(8-hydroxy-5-methyl-7-quinolyl)vinyl]-1-methyl- iodide 0.0241085022307781 -0.03649084
NSC 113951 6-Bromotoyocamycin 0.0244632509325736 0.16695596
NSC 127755 Benzenesulfonyl fluoride, 3-chloro-4-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]butyl]-, monoethanesulfonate (9CI) 0.0244632509325736 0.096358081
NSC 251805 Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester 0.0244632509325736 0.34698207
NSC 354671 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2- thiazolyl)ethylidene]hydrazide 0.0244632509325736 0.3206487
NSC 621335 Null 0.0244632509325736 0.16105399
Total:71  Current:36    [First] [Prev] [Next] [Last]